Serious About Difficult Science. Enabling Complex Molecular Innovation.
Linkers play a critical role across a growing range of therapeutic modalities, influencing stability, functionality, targeting, release characteristics and overall product performance. Whether supporting antibody-drug conjugates (ADCs), peptide-drug conjugates (PDCs), radiopharmaceuticals, oligonucleotide conjugates or other advanced therapeutic platforms, linker design and manufacture presents unique scientific and manufacturing challenges.
At Almac Sciences, we understand that successful linker development requires a deep understanding of synthetic chemistry, scalability and manufacturability. Our scientists support the development and manufacture of a broad range of linker molecules, linker intermediates and conjugation building blocks, helping clients overcome complex chemical challenges and accelerate programme progression.
Expertise Across the Development Lifecycle
Our chemistry teams have extensive experience in the development and manufacture of highly functionalised linker molecules, supporting programmes from early development through to GMP manufacture.
Capabilities include:
- Synthesis of cleavable and non-cleavable linker systems
- Development of custom linker molecules and conjugation intermediates
- Multi-step synthetic route design and optimisation
- Process development and scale-up
- Manufacture of advanced intermediates and regulatory starting materials
- Analytical characterisation and impurity control
- Development of scalable and commercially viable manufacturing routes
- Supply of complex building blocks for emerging therapeutic modalities
By combining development and manufacturing expertise within a single organisation, we help accelerate progression from proof-of-concept through to clinical and commercial supply.
Solving Complex Linker Chemistry Challenges
Linker molecules frequently present significant synthetic and manufacturing challenges. Highly functionalised structures, demanding purity requirements, difficult chemistries and challenging scale-up considerations all require specialist expertise.
Almac Sciences applies advanced synthetic methodologies, process intensification strategies and innovative enabling technologies to develop robust manufacturing processes capable of supporting future clinical and commercial requirements.
Our expertise includes:
- Heterocyclic and chiral chemistry
- Organometallic and cryogenic transformations
- High-potency chemistry capabilities
- Continuous flow chemistry
- Biocatalytic process development
- Advanced purification and isolation technologies
- High-vacuum and thin-film distillation technologies
- Physical sciences expertise, including solid-form and crystallisation support
This breadth of expertise enables us to develop practical solutions for even the most challenging linker architectures.
From Linker Development to Commercial Supply
As programmes advance towards the clinic and commercialisation, manufacturing robustness and process understanding become increasingly important.
Our integrated teams establish scalable, regulator-ready processes supported by comprehensive analytical control strategies and strong quality systems. Whether developing novel linker structures, manufacturing advanced intermediates or supporting supply chain security through regulatory starting material manufacture, we help clients move forward with confidence.
Your Partner for Difficult Linker Chemistry
As therapeutic modalities continue to evolve, linker technologies are becoming increasingly sophisticated and influential in product performance.
Almac Sciences combines scientific rigour, complex chemistry expertise and integrated manufacturing capabilities to help clients transform innovative linker concepts into reliable pharmaceutical products.
Serious About Difficult Science. Trusted for Complex Linker Development.